These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 10543057)

  • 1. [Apolipoprotein A-II].
    Takata K
    Nihon Rinsho; 1999 Sep; 57 Suppl():90-2. PubMed ID: 10543057
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lipid-poor apolipoprotein A-I, glycated apolipoprotein A-I].
    Maeda S; Suzuki M; Seishima M
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():101-4. PubMed ID: 15658274
    [No Abstract]   [Full Text] [Related]  

  • 3. [Apolipoprotein A-I, A-II, A-IV].
    Kazumi T; Yoshino G
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():98-100. PubMed ID: 15658273
    [No Abstract]   [Full Text] [Related]  

  • 4. [Apolipoprotein A-II].
    Takata K
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():101-4. PubMed ID: 11351554
    [No Abstract]   [Full Text] [Related]  

  • 5. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Distribution of the apolipoprotein-E and -E-complexes in lipoproteins of human serum with the apolipoprotein-E4/E3 phenotype].
    Hidaka H; Tozuka M; Yamauchi K; Sugano M; Nakabayashi T; Katsuyama T
    Rinsho Byori; 1997 Dec; 45(12):1172-6. PubMed ID: 9437899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study.
    Do HQ; Nazih H; Luc G; Arveiler D; Ferrières J; Evans A; Amouyel P; Cambien F; Ducimetière P; Bard JM
    Metabolism; 2009 Mar; 58(3):283-9. PubMed ID: 19217440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ApoAII controversy still in rabbit?
    Shimano H
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):1984-5. PubMed ID: 19923556
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport.
    Castro G; Nihoul LP; Dengremont C; de Geitère C; Delfly B; Tailleux A; Fievet C; Duverger N; Denèfle P; Fruchart JC; Rubin EM
    Biochemistry; 1997 Feb; 36(8):2243-9. PubMed ID: 9047326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperinsulinemia inhibits secretion of apo AI more efficiently than secretion of apoAII and apoE (insulin and secretion of apoproteins).
    Goldsztajn P; Guzdek A; Kruszelnicka-Kwiatkowska O; Guevara I; Kwaśniak M; Harwich J; Piwowarska W; Dembińska-Kieć
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():46-8. PubMed ID: 8767459
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical and genetic association of plasma apolipoprotein A-II levels with familial combined hyperlipidemia.
    Allayee H; Castellani LW; Cantor RM; de Bruin TW; Lusis AJ
    Circ Res; 2003 Jun; 92(11):1262-7. PubMed ID: 12738753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectral analysis of pig (Sus scrofa) apo HDL: Identification of pig apoA-II, a dimeric apolipoprotein.
    Puppione DL; Whitelegge JP; Yam LM; Schumaker VN
    Comp Biochem Physiol B Biochem Mol Biol; 2005 May; 141(1):89-94. PubMed ID: 15820138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentrations of apolipoprotein AI, AII, and E in plasma and lipoprotein fractions of alcoholic patients: gender differences in the effects of alcohol.
    Lin RC; Miller BA; Kelly TJ
    Hepatology; 1995 Apr; 21(4):942-9. PubMed ID: 7705804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients.
    Soedamah-Muthu SS; Colhoun HM; Taskinen MR; Idzior-Walus B; Fuller JH;
    Diabetologia; 2000 Nov; 43(11):1353-9. PubMed ID: 11126402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bezafibrate on HDL with APO A-I and APO A-II and on HDL with APO A-I without APO A-II in hyperlipidaemic patients.
    Branchi A; Rovellini A; Sommariva D
    Int J Clin Pharmacol Res; 1995; 15(4):153-8. PubMed ID: 8871265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma factors required for human apolipoprotein A-II dimerization.
    Gillard BK; Chen YS; Gaubatz JW; Massey JB; Pownall HJ
    Biochemistry; 2005 Jan; 44(2):471-9. PubMed ID: 15641771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reduction of lipoproteins with apoAI but without apoAII (LpAI) in non-insulin-dependent diabetic patients].
    Barkia A; Zouari N; Khrouf W; Ellouz F; Zouaghi H
    Ann Biol Clin (Paris); 1996; 54(2):83-6. PubMed ID: 8763631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrate.
    Taskinen MR; Sullivan DR; Ehnholm C; Whiting M; Zannino D; Simes RJ; Keech AC; Barter PJ;
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):950-5. PubMed ID: 19325138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant impact of the highly informative (CA)n repeat polymorphism of the APOA-II gene on the plasma APOA-II concentrations and HDL subfractions: The ECTIM study.
    Brousseau T; Dupuy-Gorce AM; Evans A; Arveiler D; Ruidavets JB; Haas B; Cambou JP; Luc G; Ducimetière P; Amouyel P; Helbecque N
    Am J Med Genet; 2002 Jun; 110(1):19-24. PubMed ID: 12116266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Subfractionation of serum high density lipoproteins and its clinical significance].
    Hua F; Maeda S; Seishima M; Noma A
    Rinsho Byori; 1996 Aug; 44(8):802-6. PubMed ID: 8816069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.